Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
IBM introduces Storage as a Service on SoftLayer for High Performance Data Management in Cloud
Monday, July 28, 2014
IBM introduces Storage as a Service on SoftLayer for High Performance Data Management in Cloud

MDxI Launches LabFile Data Resource
Friday, July 25, 2014
New standard for defining and targeting US clinical laboratory universe.

PAC Releases New Lab Instrument Data Integration Software, IRIS
Saturday, July 19, 2014
IRIS provides innovative results management and reporting software for PAC laboratory instruments.

New Software for Malvern’s NanoSight NTA Systems
Friday, July 18, 2014
NTA 3.0 from Malvern improves user experience and enhances performance.

Mosaic Assay Requesting Module Increases Assay Efficiency, Saving Time and Cost
Friday, July 11, 2014
New module for Titian Software’s leading sample management software will minimize the use of assay resources.

Cresset Announces the Release of Forge V10.3
Tuesday, July 08, 2014
Significant new science, visualization and integration for leading ligand-based drug design workbench.

BioTek Launches Enhanced SiLA Compliant Software
Tuesday, July 08, 2014
BioTek’s LHC™ SiLA software for washers/dispensers.

BioTek Launches Enhanced SiLA Compliant Software
Tuesday, July 08, 2014
BioTek’s LHC™ SiLA software for washers/dispensers.

Schleicher GRED® Software from Schleicher Electronic
Friday, July 04, 2014
A new and unique type of software for retained data.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 870
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv